Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Birth Defects Research
|
January 18, 2019
The effects of nifedipine and ivabradine on the functionality of the early rat embryonic heart. Are these drugs a risk in early human pregnancy?
Helen E Ritchie, Carolina Telenius, Elin Gustaffson, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
February 27, 2017
Abnormal pregnancy outcome associated with high-dose maternal tranylcypromine therapy: Case report and literature review
Debra Kennedy, William S Webster, Majella Hill, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology
|
June 17, 2008
Acardiac fetus: evidence in support of a vascular/hypoxia pathogenesis for isolated oral clefting
Kenneth Lyons Jones, William S Webster, Keith K Vaux, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
April 19, 2005
Maternal antioxidant supplementation does not reduce the incidence of phenytoin-induced cleft lip and related malformations in rats
Dominique Abela, Andrew M Howe, Diana A Oakes, et al.
Current Pharmaceutical Design
|
April 14, 2006
The relationship between cleft lip, maxillary hypoplasia, hypoxia and phenytoin
William S Webster, Andrew M Howe, Dominique Abela, et al.
Birth Defects Research
|
October 6, 2023
Recommendation to change the peer review process
L David Wise, Stephen B Harris, William S Webster, et al.
Journal of Pharmacological and Toxicological Methods
|
August 6, 2014
A comparison of drug-induced cardiotoxicity in rat embryos cultured in human serum or protein free media
Helen E Ritchie, Cecilie Haaland Svensson, Mats F Nilsson, et al.
Hypoxia (Auckland, N.Z.)
|
November 24, 2016
Control of the heart rate of rat embryos during the organogenic period
Helen E Ritchie, Carolina Ragnerstam, Elin Gustafsson, et al.
Current Pharmaceutical Design
|
November 6, 2007
New proposals for testing drugs with IKr-blocking activity to determine their teratogenic potential
Miriam Karlsson, Bengt R Danielsson, Mats F Nilsson, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
March 19, 2013
The teratogenic effect of dofetilide during rat limb development and association with drug-induced bradycardia and hypoxia in the embryo
Helen E Ritchie, Deena H Ababneh, Diana J Oakes, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Birth Defects Research
|
January 18, 2019
The effects of nifedipine and ivabradine on the functionality of the early rat embryonic heart. Are these drugs a risk in early human pregnancy?
Helen E Ritchie, Carolina Telenius, Elin Gustaffson, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
February 27, 2017
Abnormal pregnancy outcome associated with high-dose maternal tranylcypromine therapy: Case report and literature review
Debra Kennedy, William S Webster, Majella Hill, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology
|
June 17, 2008
Acardiac fetus: evidence in support of a vascular/hypoxia pathogenesis for isolated oral clefting
Kenneth Lyons Jones, William S Webster, Keith K Vaux, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
April 19, 2005
Maternal antioxidant supplementation does not reduce the incidence of phenytoin-induced cleft lip and related malformations in rats
Dominique Abela, Andrew M Howe, Diana A Oakes, et al.
Current Pharmaceutical Design
|
April 14, 2006
The relationship between cleft lip, maxillary hypoplasia, hypoxia and phenytoin
William S Webster, Andrew M Howe, Dominique Abela, et al.
Birth Defects Research
|
October 6, 2023
Recommendation to change the peer review process
L David Wise, Stephen B Harris, William S Webster, et al.
Journal of Pharmacological and Toxicological Methods
|
August 6, 2014
A comparison of drug-induced cardiotoxicity in rat embryos cultured in human serum or protein free media
Helen E Ritchie, Cecilie Haaland Svensson, Mats F Nilsson, et al.
Hypoxia (Auckland, N.Z.)
|
November 24, 2016
Control of the heart rate of rat embryos during the organogenic period
Helen E Ritchie, Carolina Ragnerstam, Elin Gustafsson, et al.
Current Pharmaceutical Design
|
November 6, 2007
New proposals for testing drugs with IKr-blocking activity to determine their teratogenic potential
Miriam Karlsson, Bengt R Danielsson, Mats F Nilsson, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
March 19, 2013
The teratogenic effect of dofetilide during rat limb development and association with drug-induced bradycardia and hypoxia in the embryo
Helen E Ritchie, Deena H Ababneh, Diana J Oakes, et al.
Page
of 3